-+ 0.00%
-+ 0.00%
-+ 0.00%

Kewaunee Scientific releases transcript of 2026 annual shareholder meeting

PUBT·08/26/2026 17:31:44
Listen to the news
Kewaunee Scientific releases transcript of 2026 annual shareholder meeting
  • Kewaunee published a transcript from its virtual 2026 annual shareholder meeting attended by shareholders.
  • Revenue totaled $282 million for the year ended April 30, 2026; EBITDA rose to $22.4 million.
  • Order backlog was $165.9 million at April 30, 2026, down from $214.6 million, citing large international project completions.
  • Long-term debt fell by about $20 million; NuAire seller notes were repaid; debt-to-equity improved to 0.61 from 0.99.
  • Lab Products Group sales increased 19.8% to $214.9 million; International segment sales rose 9.9% to $67.1 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief on August 26, 2026, and is solely responsible for the information contained therein.